TABLE 3.
Characteristics of Deceased Patients
| Sex, Age, yr | Disease Duration | Disease Phase | EDSS | Therapy | Comorbidities |
|---|---|---|---|---|---|
| M, 63 | 33 | SPMS | 7 | No therapy | Diabetes |
| M, 67 | 2 | PPMS | 7.5 | No therapy | CHD, hypertension, HBV |
| M, 68 | 21 | SPMS | 6 | Dimethyl fumarate | Cerebrovascular disease, hypertension, depression, TBC |
| F, 57 | 20 | SPMS | 9 | No therapy | No |
| M, 76 | 17 | SPMS | 6.5 | No therapy | CHD, hypertension, depression, dyslipidemia |
| F, 52 | 1 | RRMS | 5 | Natalizumab | No |
| F, 50 | 27 | SPMS | 6 | Ocrelizumab | No |
| M, 59 | 33 | SPMS | 9 | No therapy | No |
| F, 68 | 19 | SPMS | 5.5 | No therapy | No |
| F, 54 | 20 | SPMS | 7 | Rituximab | No |
| M, 64 | 10 | RRMS | 2 | Glatiramer‐acetate | No |
| M, 63 | 33 | SPMS | 6.5 | No therapy | Diabetes, bipolar disorder |
| M, 60 | 30 | SPMS | 9 | No therapy | Hypertension, cerebrovascular disease, CHD |
CHD = coronary heart disease; F = female; HBV = hepatitis B virus; M = male; PPMS = primary progressive multiple sclerosis; RRMS = relapsing–remitting multiple sclerosis; SPMS = secondary progressive multiple sclerosis; TBC = tuberculosis.